Synthetic LXR agonist attenuates plaque formation in apoE-/- mice without inducing liver steatosis and hypertriglyceridemia (Q24657127)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Synthetic LXR agonist attenuates plaque formation in apoE-/- mice without inducing liver steatosis and hypertriglyceridemia
scientific article

    Statements

    Synthetic LXR agonist attenuates plaque formation in apoE-/- mice without inducing liver steatosis and hypertriglyceridemia (English)
    0 references
    0 references
    Adelheid Kratzer
    0 references
    Marlene Buchebner
    0 references
    Thomas Pfeifer
    0 references
    Tatjana M Becker
    0 references
    Georg Uray
    0 references
    Makoto Miyazaki
    0 references
    Shinobu Miyazaki-Anzai
    0 references
    Birgit Ebner
    0 references
    Prakash G Chandak
    0 references
    Rajendra S Kadam
    0 references
    Emine Calayir
    0 references
    Nora Rathke
    0 references
    Helmut Ahammer
    0 references
    Branislav Radovic
    0 references
    Gerald Hoefler
    0 references
    Uday B Kompella
    0 references
    Guenter Fauler
    0 references
    Moshe Levi
    0 references
    Sanja Levak-Frank
    0 references
    Gerhard M Kostner
    0 references
    Dagmar Kratky
    0 references
    February 2009
    0 references
    50
    0 references
    2
    0 references
    312-26
    0 references

    Identifiers

    0 references
    0 references
     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit